Task: Answer the multiple-choice question.
Question: Which drug exhibits a 27.551% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) CC(C)CC(=O)NC(NC(=O)CC(C)C)c1cccc([N+](=O)[O-])c1
b) Cc1ccc(S(=O)(=O)N2CC(C)N(C(=O)N3CCOCC3)C2C)cc1
c) COCCNC(=O)C(c1ccc(C)cc1)N(C(=O)CCC(=O)Nc1ccccn1)c1ccc(F)cc1
d) COc1ccc(S(=O)(=O)N2CC(=O)Nc3ccccc32)cc1C
Answer: b. Cc1ccc(S(=O)(=O)N2CC(C)N(C(=O)N3CCOCC3)C2C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)N2CC(C)N(C(=O)N3CCOCC3)C2C)cc1
Cc1ccc(S(=O)(=O)N2CC(C)N(C(=O)N3CCOCC3)C2C)cc1
[2,5-dimethyl-3-(4-methylphenyl)sulfonylimidazolidin-1-yl]-morpholin-4-ylmethanone